Autres langues Omnicell, Inc.

Actions

OMCL

US68213N1090

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 23/09/2026			Varia. 5j.	Varia. 1 janv.
32,99 ^USD	-0,54%		+1,73%	-27,17%

03/09	TraceLink, Inc. et Omnicell, Inc. intègrent une solution de conformité à la DSCSA dans les opérations de pharmacie hospitalière	CI
14/08	US Physical Therapy nomme Nchacha Etta au poste de directeur financier	MT

Autres langues

03/09	Tracelink, Inc. and Omnicell, Inc. Integrate Dscsa Compliance Solution into Hospital Pharmacy Operations
03/09	TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
31/08	Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
14/08	US Physical Therapy Names Nchacha Etta as Chief Financial Officer
05/08	Tranche Update on Omnicell, Inc.'s Equity Buyback Plan announced on May 22, 2025.
30/07	EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
30/07	Omnicell, Inc. Provides Earnings Guidance for the Third Quarter 2026 and Updates Earnings Guidance Full Year 2026
30/07	Omnicell, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
30/07	Omnicell Q2 Non-GAAP Net Income, Revenue Increase; 2026 Non-GAAP EPS Outlook Lifted
30/07	(OMCL) Omnicell, Inc. Expects Q3 Revenue Range $301.0M - $307.0M
30/07	(OMCL) Omnicell, Inc. Expects Q3 Adjusted EPS Range $0.35 - $0.43
30/07	Earnings Flash (OMCL) Omnicell, Inc. Reports Q2 Revenue $312.2M, vs. FactSet Est of $310.2M
30/07	Earnings Flash (OMCL) Omnicell, Inc. Posts Q2 Adjusted EPS $0.94 per Share, vs. FactSet Est of $0.47
30/07	Omnicell: Q2 Earnings Snapshot
30/07	Omnicell Announces Second Quarter 2026 Financial Results
13/07	Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
01/07	Omnicell, Inc. Announces Executive Changes
01/07	Omnicell Names Nnamdi Njoku as President
01/07	Nnamdi Njoku Appointed President of Omnicell
29/06	Omnicell, Inc.(NasdaqGS:OMCL) added to Russell 2000 Value-Defensive Index
29/06	Omnicell, Inc.(NasdaqGS:OMCL) added to Russell 2000 Defensive Index
08/06	Omnicell, Inc. Announces Appointment of Dan Mandoli to Senior Vice President and General Manager, Specialty Pharmacy Services
08/06	Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business
02/06	Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
23/05	Omnicell Inc Faces FDA Class I Recall For Label Stock Used With Ivstation Device